314 related articles for article (PubMed ID: 11414353)
1. Structure-function relationships of complement receptor type 1.
Krych-Goldberg M; Atkinson JP
Immunol Rev; 2001 Apr; 180():112-22. PubMed ID: 11414353
[TBL] [Abstract][Full Text] [Related]
2. Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitors.
Krych-Goldberg M; Hauhart RE; Porzukowiak T; Atkinson JP
J Immunol; 2005 Oct; 175(7):4528-35. PubMed ID: 16177096
[TBL] [Abstract][Full Text] [Related]
3. Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases.
Krych-Goldberg M; Hauhart RE; Subramanian VB; Yurcisin BM; Crimmins DL; Hourcade DE; Atkinson JP
J Biol Chem; 1999 Oct; 274(44):31160-8. PubMed ID: 10531307
[TBL] [Abstract][Full Text] [Related]
4. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
[TBL] [Abstract][Full Text] [Related]
5. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
Subramanian VB; Clemenza L; Krych M; Atkinson JP
J Immunol; 1996 Aug; 157(3):1242-7. PubMed ID: 8757632
[TBL] [Abstract][Full Text] [Related]
6. A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases.
Kuttner-Kondo LA; Dybvig MP; Mitchell LM; Muqim N; Atkinson JP; Medof ME; Hourcade DE
J Biol Chem; 2003 Dec; 278(52):52386-91. PubMed ID: 14561755
[TBL] [Abstract][Full Text] [Related]
7. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
Seya T; Holers VM; Atkinson JP
J Immunol; 1985 Oct; 135(4):2661-7. PubMed ID: 3161944
[TBL] [Abstract][Full Text] [Related]
8. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
Wong WW; Farrell SA
J Immunol; 1991 Jan; 146(2):656-62. PubMed ID: 1670949
[TBL] [Abstract][Full Text] [Related]
9. Structure-function analysis of the active sites of complement receptor type 1.
Krych M; Hauhart R; Atkinson JP
J Biol Chem; 1998 Apr; 273(15):8623-9. PubMed ID: 9535836
[TBL] [Abstract][Full Text] [Related]
10. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
Pangburn MK
J Immunol; 1986 Mar; 136(6):2216-21. PubMed ID: 2419425
[TBL] [Abstract][Full Text] [Related]
11. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships within the N-terminal short consensus repeats (SCR) of human CR1 (C3b/C4b receptor, CD35): SCR 3 plays a critical role in inhibition of the classical and alternative pathways of complement activation.
Mossakowska D; Dodd I; Pindar W; Smith RA
Eur J Immunol; 1999 Jun; 29(6):1955-65. PubMed ID: 10382758
[TBL] [Abstract][Full Text] [Related]
13. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.
Kozono H; Kinoshita T; Kim YU; Takata-Kozono Y; Tsunasawa S; Sakiyama F; Takeda J; Hong K; Inoue K
J Biol Chem; 1990 Aug; 265(24):14444-9. PubMed ID: 2387864
[TBL] [Abstract][Full Text] [Related]
14. Complement receptor is an inhibitor of the complement cascade.
Iida K; Nussenzweig V
J Exp Med; 1981 May; 153(5):1138-50. PubMed ID: 6910481
[TBL] [Abstract][Full Text] [Related]
15. Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.
Park HJ; Guariento M; Maciejewski M; Hauhart R; Tham WH; Cowman AF; Schmidt CQ; Mertens HD; Liszewski MK; Hourcade DE; Barlow PN; Atkinson JP
J Biol Chem; 2014 Jan; 289(1):450-63. PubMed ID: 24214979
[TBL] [Abstract][Full Text] [Related]
16. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.
Klickstein LB; Wong WW; Smith JA; Weis JH; Wilson JG; Fearon DT
J Exp Med; 1987 Apr; 165(4):1095-112. PubMed ID: 2951479
[TBL] [Abstract][Full Text] [Related]
17. Identification of complement receptor type 1-related proteins on primate erythrocytes.
Nickells MW; Subramanian VB; Clemenza L; Atkinson JP
J Immunol; 1995 Mar; 154(6):2829-37. PubMed ID: 7876553
[TBL] [Abstract][Full Text] [Related]
18. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding.
Krych M; Hourcade D; Atkinson JP
Proc Natl Acad Sci U S A; 1991 May; 88(10):4353-7. PubMed ID: 1827918
[TBL] [Abstract][Full Text] [Related]
19. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
Medof ME; Nussenzweig V
J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis.
Krych M; Clemenza L; Howdeshell D; Hauhart R; Hourcade D; Atkinson JP
J Biol Chem; 1994 May; 269(18):13273-8. PubMed ID: 8175757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
